Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Castlerigg Master Investments is a hedge fund vehicle managed by Sandell Asset Management, an international alternative investment firm founded by Tom Sandell. The fund primarily employs event-driven investment strategies, including merger arbitrage, corporate restructuring, and activist investing. While it is not a life sciences or biotechnology company, it frequently appears as a significant institutional investor in the healthcare and pharmaceutical sectors, often taking positions in companies involved in mergers or acquisitions. The entity serves as a financial vehicle rather than a developer of therapeutic products or platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Castlerigg Master Investments.